Showing results (1331-1340 of 1,547) with videos related to

Sort By:
Pageof 155
Neuro-Oncology|February 8, 2017
Germline and somatic BAP1 mutations in high-grade rhabdoid meningiomasGanesh M Shankar, Malak Abedalthagafi, Rachael A Vaubel, et al.
Medrxiv : the Preprint Server for Health Sciences|August 30, 2024
Surgical window of opportunity trial reveals mechanisms of response and resistance to navtemadlin (KRT-232) in patients with recurrent glioblastomaVeronica Rendo, Eudocia Q Lee, Connor Bossi, et al.
The Lancet. Oncology|November 1, 2025
Vorasidenib in IDH1-mutant or IDH2-mutant low-grade glioma (INDIGO): secondary and exploratory endpoints from a randomised, double-blind, placebo-controlled, phase 3 trialTimothy F Cloughesy, Martin J van den Bent, Mehdi Touat, et al.
Neuro-Oncology|July 6, 2014
Recursive partitioning analysis of prognostic variables in newly diagnosed anaplastic oligodendroglial tumorsKatherine S Panageas, Anne S Reiner, Fabio M Iwamoto, et al.
Neuro-Oncology|October 14, 2022
Isocitrate dehydrogenase (IDH) mutant gliomas: A Society for Neuro-Oncology (SNO) consensus review on diagnosis, management, and future directionsJulie J Miller, L Nicolas Gonzalez Castro, Samuel McBrayer, et al.
JCO Precision Oncology|September 14, 2020
Exploring Predictors of Response to Dacomitinib in <i>EGFR</i>-Amplified Recurrent GlioblastomaAndrew S Chi, Daniel P Cahill, David A Reardon, et al.
Nature Communications|May 10, 2018
Recurrent hotspot mutations in HRAS Q61 and PI3K-AKT pathway genes as drivers of breast adenomyoepitheliomasFelipe C Geyer, Anqi Li, Anastasios D Papanastasiou, et al.
JAMA Oncology|July 17, 2015
Rapid Intraoperative Molecular Characterization of GliomaGanesh M Shankar, Joshua M Francis, Mikael L Rinne, et al.
Nature Communications|December 31, 2024
Neoadjuvant anti-PD1 immunotherapy for surgically accessible recurrent glioblastoma: clinical and molecular outcomes of a stage 2 single-arm expansion cohortJ Ricardo McFaline-Figueroa, Lu Sun, Gilbert C Youssef, et al.
Neuro-Oncology|February 14, 2022
Prospective validation of a new imaging scorecard to assess leptomeningeal metastasis: A joint EORTC BTG and RANO effortEmilie Le Rhun, Patrick Devos, Sebastian Winklhofer, et al.
Pageof 155